|
ZNF621 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.79390000004864E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.995930E-04 |
| Normal-vs-Stage2 |
4.770200E-04 |
| Normal-vs-Stage3 |
1.35580000004687E-06 |
| Normal-vs-Stage4 |
3.987100E-04 |
| Stage1-vs-Stage2 |
4.058000E-01 |
| Stage1-vs-Stage3 |
5.518400E-02 |
| Stage1-vs-Stage4 |
5.744400E-01 |
| Stage2-vs-Stage3 |
5.873800E-01 |
| Stage2-vs-Stage4 |
7.982400E-01 |
| Stage3-vs-Stage4 |
3.828800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81928999999359E-05 |
| Normal-vs-AfricanAmerican |
1.019830E-02 |
| Normal-vs-Asian |
2.987900E-02 |
| Caucasian-vs-AfricanAmerican |
9.375000E-01 |
| Caucasian-vs-Asian |
1.637400E-01 |
| AfricanAmerican-vs-Asian |
3.992400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.07209999999658E-05 |
| Normal-vs-Female |
1.89791999999356E-05 |
| Male-vs-Female |
9.222800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.601700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.08989999999076E-05 |
| Normal-vs-Age(61-80Yrs) |
3.76629999999656E-05 |
| Normal-vs-Age(81-100Yrs) |
3.436400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.336800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.986400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.366800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.329400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.819400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.415600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.162100E-02 |
| Classical-VS-Follicular |
1.761030E-04 |
| Classical-VS-Other |
3.771200E-01 |
| Classical-VS-Normal |
1.237580E-03 |
| Tall-VS-Follicular |
8.691000E-01 |
| Tall-VS-Other |
7.676800E-01 |
| Tall-VS-Normal |
8.32299999999897E-05 |
| Follicular-VS-Other |
7.226200E-01 |
| Follicular-VS-Normal |
3.40719999991634E-07 |
| Other-VS-Normal |
5.512100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45709999999733E-05 |
| Normal-vs-N1 |
1.502980E-03 |
| N0-vs-N1 |
6.913200E-01 |
|
|
